Fertilizers and Agricultural Chemicals

HC CHEMICAL

HC CHEMICAL released FY2026 Q1 earnings on April 27 After-Market BJT, actual revenue CNY 37.23 M, actual EPS CNY 0.0026

HC CHEMICAL released FY2025 Annual Earnings on April 23 Pre-Market (BJT), actual revenue CNY 179.68 M, actual EPS CNY 0.02

HC CHEMICAL released FY2025 Q4 earnings on April 23 Pre-Market (BJT), actual revenue CNY 50.23 M, actual EPS CNY -0.0067

HC CHEMICAL to Release FY2026 Q1 Earnings on April 28 After-Market (BJT)

HC CHEMICAL to Release FY2025 Earnings Report on April 24, 2026 Pre-Market BJT

HC CHEMICAL released FY2025 Q3 earnings on October 27 After-Market (BJT), actual revenue CNY 48.62 M, actual EPS CNY 0.0111

HC CHEMICAL released FY2025 9 Months earnings on October 27 After-Market (BJT), actual revenue CNY 129.45 M, actual EPS CNY 0.0217

HC CHEMICAL to Release FY2025 Q3 Earnings on October 28 After-Market (BJT)

HC CHEMICAL released FY2025 Q2 earnings on August 27 Pre-Market (BJT), actual revenue CNY 40 M, actual EPS CNY 0.0068

HC CHEMICAL released FY2025 Semi-Annual earnings on August 27 Pre-Market BJT, actual revenue CNY 80.83 M, actual EPS CNY 0.0105

HC CHEMICAL to Release FY2025 Semi-Annual Earnings on August 28, 2025 (BJT)

Huahe Shares Plans to Set Up a Venture Capital Fund

Huahua Chemical Shares ESG Rating Announced

HuaShi Chemical to Fully Introduce CDMO Projects with No Plans for Battery-Grade Cellulose Production in 2023

HuaHua Corporation Announces Q1 2025 Financial Results

HC CHEMICAL released FY2025 Q1 earnings on April 28 After-Market (BJT), actual revenue CNY 40.83 M, actual EPS CNY 0.0037

Hehua Shares 2024 Annual Report Shows Significant Profit Growth

HC Chemical released FY2024 Annual Earnings on April 25 After-Market (BJT), actual revenue CNY 211.52 M, actual EPS CNY 0.22

HC Chemical released FY2024 Q4 earnings on April 25 After-Market (BJT), actual revenue CNY 44.82 M, actual EPS CNY -0.0001

HC CHEMICAL to Release FY2025 Q1 Earnings Report on April 29 After-Market BJT

000953

According to the Zhitong Finance APP, HC CHEMICAL released its third-quarter report for 2025. In the first three quarters, the company achieved an operating income of 129 million yuan, a year-on-year decrease of 22.34%. The net profit attributable to shareholders of the listed company was 7.9332 million yuan, a year-on-year decrease of 89.99%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 7.5389 million yuan, a year-on-year increase of 576.51%

Zhitong

HC CHEMICAL released its performance for the first three quarters, with a net profit attributable to the parent company of 7.9332 million yuan, a year-on-year decrease of 89.99%

HC CHEMICAL announced that its controlling shareholder Ningbo Yin Yi Holdings Co., Ltd. has signed an asset transfer agreement with Ningbo Zhongzhe Ruihe Enterprise Management Consulting Co., Ltd., intending to transfer 87 million shares (accounting for 23.76%) and receivables to Zhongzhe Ruihe. If the transaction is completed, the controlling shareholder will change from Yin Yi Holdings to Zhongzhe Ruihe, and the actual controller will change from Xiong Xuqiang to Yang Herong

The actual controller of HC CHEMICAL is proposed to be changed to Yang Herong

HC CHEMICAL announced that in the first half of 2025, the operating revenue was 80.8304 million yuan, a year-on-year decrease of 37.02%. The net profit was 3.8382 million yuan, a year-on-year increase of 45.56%. The company plans not to distribute cash dividends, not to issue bonus shares, and not to increase capital through reserves

HC CHEMICAL: Net profit in the first half of 2025 increased by 45.56% year-on-year

HC CHEMICAL announced that its controlling shareholder, YinYi Holdings, has reached a cooperation intention with Beijing Shengding Technology Co., Ltd., intending to transfer all shares held by YinYi Holdings to Beijing Shengding or its designated party. If the transaction is implemented, the actual controller of the company will change. The company's stock will resume trading on August 7, 2025

HC CHEMICAL's actual controller may change, and trading will resume on August 7

HC CHEMICAL announced that its stock will continue to be suspended from trading starting from the morning of August 4, 2025, with the suspension expected to last no more than 3 trading days. Previously, the company's controlling shareholder, YinYi Holdings, was planning to transfer its 23.76% stake in the company, which may lead to a change in the company's control. Currently, no formal transaction agreements have been signed by the parties involved, and further verification and negotiation on related matters are ongoing

HC CHEMICAL: The controlling shareholder, Yinyi Holdings, is planning to transfer its 23.76% stake in the company. The stock continues to be suspended from trading

According to the Zhitong Finance APP, HC CHEMICAL announced that the company recently received a notice from its controlling shareholder Ningbo Yinyi Holdings Co., Ltd., which is planning to transfer equity. This matter may lead to a change in the company's controlling shareholder and actual controller. Currently, no formal transaction agreements have been signed by the parties involved, and further verification and negotiation on the related matters are planned. The company's stock will be suspended from trading starting from the morning of July 31, 2025 (Thursday), with the suspension expected to last no more than 2 trading days

HC CHEMICAL's control may change hands, trading suspended from July 31

301047

301509

300149

301333

301393

The CRO concept saw a short-term surge, with HC CHEMICAL hitting the limit up, and Kingchem, ChemPartner, R&G Pharma, Highfine, and Sino Biological all rising

Sino Biological

Kingchem

ChemPartner

R&G Pharma

Highfine

300204

688266

688331

09995

688068

688302

In the morning session, Staidson BioPharm surged over 15%, HC CHEMICAL hit the daily limit, and Hinova, Chengda Pharmaceutical, Zelgen, RemeGen, Hotgen, and BeiGene followed suit

Staidson BioPharm

Zelgen

RemeGen

REMEGEN

Hotgen

Hinova

CHENGDA PHARMA

BEONE MEDICINES

Innovative drug concept was active at the beginning of the session, with Staidson BioPharm rising over 15%

According to the Zhitong Finance APP, HC CHEMICAL released its Q1 2025 report. In the first quarter, the company achieved operating revenue of 40.8331 million yuan, a year-on-year decrease of 34.05%. The net profit attributable to shareholders of the listed company was 1.362 million yuan, and the net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 1.2438 million yuan

HC CHEMICAL released its first-quarter performance, with a net profit attributable to shareholders of 1.362 million yuan

603669

300267

The chemical pharmaceutical sector has shown strong fluctuations, with HC CHEMICAL and Lionco hitting the daily limit, ER-KANG rising over 10%, and Luoxin Pharmaceutical and Yifang Biotechnology both surging

Lionco

ER-KANG

Luoxin Pharmaceutical

InventisBio

The chemical pharmaceutical sector fluctuated and strengthened, with HC CHEMICAL and Lionco hitting the limit-up

HC CHEMICAL(000953.SZ)